ProAir Digihaler is the first digital inhaler with built-in sensors that connects to a mobile application and provides data on inhaler use to patients with asthma and chronic obstructive pulmonary disease (COPD).
Nabriva Therapeutics announced the submission of 2 NDAs to the FDA for the oral and IV formulations of lefamulin for the treatment of community-acquired bacterial pneumonia.
A study published in Circulation has found a reduced risk of cardiovascular (CV) death in heart failure patients when they are given routine influenza vaccinations.
Currently, same-day delivery is available only in Dallas, Chicago, New York City, Gainesville, Miami, Tampa, and Fort Lauderdale; this program will be expanded in 2019.
The approval was based on data from the IMpower 150 trial, an open-label study involving 1202 patients with stage IV metastatic NSq NSCLC who had not received prior chemotherapy for metastatic disease, but could have received prior EGFR or ALK kinase inhibitor if appropriate, regardless of PD-L1 or T-effector gene status and ECOG performance status 0 or 1.
A meta-analysis of anti-inflammatory agents for the treatment of pediatric OSA found that montelukast plus intranasal steroids or montelukast alone may benefit patients with mild OSA.
The generic version of the EpiPen Jr (epinephrine injection, USP) 0.15mg as well as additional supply of the generic version of the EpiPen Auto-Injector 0.3mg will be made available in 2019.
More than 67% of patients who received AR101 were able to ingest a dose of 600 mg or more of peanut protein at the exit food challenge, without dose-limiting symptoms
The US Department of Health and Human Services has released the second edition of the Physical Activity Guidelines for Americans at the American Heart Association’s Scientific Sessions meeting.
Several asthma and allergy groups expressed “deep concern” over the recent FDA approval of Primatene MIST.
